PMID- 28322314 OWN - NLM STAT- MEDLINE DCOM- 20181109 LR - 20201209 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 7 DP - 2017 Mar 21 TI - The prognostic value of N-terminal proB-type natriuretic peptide in patients with acute respiratory distress syndrome. PG - 44784 LID - 10.1038/srep44784 [doi] LID - 44784 AB - We investigated whether N-terminal proB-type natriuretic peptide (NT-proBNP) predicts the prognosis of patients with acute respiratory distress syndrome (ARDS). Between December 1, 2012, and May 31, 2015, this observational study recruited patients admitted to our tertiary medical center who met the Berlin criteria for ARDS and who had their NT-proBNP measured. The main outcome was 28-day mortality. We enrolled 61 patients who met the Berlin criteria for ARDS: 7 were classified as mild, 29 as moderate, and 25 as severe. The median APACHE II scores were 23 (interquartile range [IQR], 18-28), and SOFA scores were 11 (IQR, 8-13). The median lung injury score was 3.0 (IQR, 2.50-3.25), and the median level of NT-proBNP was 2011 pg/ml (IQR, 579-7216). Thirty-four patients died during this study, and the 28-day mortality rate was 55.7%. Patients who die were older and had significantly (all p < 0.05) higher APACHE II scores and NT-proBNP levels than did patients who survived. Multivariate analysis identified age (HR: 1.546, 95% CI: 1.174-2.035, p = 0.0019) and NT-proBNP (HR: 1.009, 95% CI: 1.004-1.013, p = 0.0001) as significant risk factors of death. NT-proBNP was associated with poor outcomes for patients with ARDS, and its level predicted mortality. FAU - Lai, Chih-Cheng AU - Lai CC AD - Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Taiwan. FAU - Sung, Mei-I AU - Sung MI AD - Departments of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan. FAU - Ho, Chung-Han AU - Ho CH AD - Departments of Medical Research, Chi Mei Medical Center, Tainan, Taiwan. AD - Chia Nan University of Pharmacy &Science, Tainan, Taiwan. FAU - Liu, Hsiao-Hua AU - Liu HH AD - Departments of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan. FAU - Chen, Chin-Ming AU - Chen CM AD - Chia Nan University of Pharmacy &Science, Tainan, Taiwan. AD - Departments of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan. FAU - Chiang, Shyh-Ren AU - Chiang SR AD - Departments of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan. AD - Chia Nan University of Pharmacy &Science, Tainan, Taiwan. FAU - Chao, Chien-Ming AU - Chao CM AD - Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Taiwan. FAU - Liu, Wei-Lun AU - Liu WL AD - Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Taiwan. FAU - Hsing, Shu-Chen AU - Hsing SC AD - Departments of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan. FAU - Cheng, Kuo-Chen AU - Cheng KC AD - Departments of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan. AD - Department of Safety Health and Environmental Engineering, Chung Hwa University of Medical Technology, Tainan, Taiwan. LA - eng PT - Journal Article DEP - 20170321 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Peptide Fragments) RN - 0 (pro-brain natriuretic peptide (1-76)) RN - 114471-18-0 (Natriuretic Peptide, Brain) SB - IM MH - Aged MH - Demography MH - Female MH - Humans MH - Male MH - Middle Aged MH - Natriuretic Peptide, Brain/*metabolism MH - Peptide Fragments/*metabolism MH - Prognosis MH - ROC Curve MH - Respiratory Distress Syndrome/*diagnosis/mortality MH - Survival Analysis MH - Treatment Outcome PMC - PMC5359608 COIS- The authors declare no competing financial interests. EDAT- 2017/03/23 06:00 MHDA- 2018/11/10 06:00 PMCR- 2017/03/21 CRDT- 2017/03/22 06:00 PHST- 2016/12/16 00:00 [received] PHST- 2017/02/13 00:00 [accepted] PHST- 2017/03/22 06:00 [entrez] PHST- 2017/03/23 06:00 [pubmed] PHST- 2018/11/10 06:00 [medline] PHST- 2017/03/21 00:00 [pmc-release] AID - srep44784 [pii] AID - 10.1038/srep44784 [doi] PST - epublish SO - Sci Rep. 2017 Mar 21;7:44784. doi: 10.1038/srep44784.